• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含具有抗铜绿假单胞菌活性的乳酸菌的吸入性粉末的研制。

Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa.

机构信息

Food and Drug Department, University of Parma, Parma, Italy.

Risk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Parma, Italy.

出版信息

Int J Antimicrob Agents. 2024 Jan;63(1):107001. doi: 10.1016/j.ijantimicag.2023.107001. Epub 2023 Oct 13.

DOI:10.1016/j.ijantimicag.2023.107001
PMID:37839715
Abstract

OBJECTIVES

The aim of the project was to develop and characterise powders containing a probiotic (Lactiplantibacillus plantarum [Lpb. plantarum], Lacticaseibacillus rhamnosus, or Lactobacillus acidophilus) to be administered to the lung for the containment of pathogen growth in patients with lung infections.

METHODS

The optimised spray drying process for the powder manufacturing was able to preserve viability of the bacteria, which decreased of only one log unit and was maintained up to 30 days.

RESULTS

Probiotic powders showed a high respirability (42%-50% of particles had a size < 5 µm) suitable for lung deposition and were proven safe on A549 and Calu-3 cells up to a concentration of 10 colony-forming units/mL. The Lpb. plantarum adhesion to both cell lines tested was at least 10%. Surprisingly, Lpb. plantarum powder was bactericidal at a concentration of 10 colony-forming units/mL on P. aeruginosa, whereas the other two strains were bacteriostatic.

CONCLUSION

This work represents a promising starting point to consider a probiotic inhalation powder a value in keeping the growth of pathogenic microflora in check during the antibiotic inhalation therapy suspension in cystic fibrosis treatment regimen. This approach could also be advantageous for interfering competitively with pathogenic bacteria and promoting the restoration of the healthy microbiota.

摘要

目的

该项目旨在开发并表征含有益生菌(植物乳杆菌[Lpb. plantarum]、鼠李糖乳杆菌或嗜酸乳杆菌)的粉末,将其施用于肺部,以抑制肺部感染患者病原体的生长。

方法

粉末制造的优化喷雾干燥工艺能够保持细菌的活力,细菌的活力仅下降了一个对数单位,并能维持 30 天。

结果

益生菌粉末具有较高的可呼吸性(42%-50%的颗粒大小<5 µm),适合肺部沉积,并在 A549 和 Calu-3 细胞上证明在 10 菌落形成单位/mL 的浓度下是安全的。Lpb. plantarum 对两种测试细胞系的黏附率至少为 10%。令人惊讶的是,Lpb. plantarum 粉末在 10 菌落形成单位/mL 的浓度下对铜绿假单胞菌具有杀菌作用,而其他两种菌株则具有抑菌作用。

结论

这项工作为考虑将益生菌吸入粉末作为在囊性纤维化治疗方案中抗生素吸入治疗暂停期间抑制病原微生物生长的一种有价值的方法提供了一个有希望的起点。这种方法还可能有利于与病原菌竞争,并促进健康微生物群的恢复。

相似文献

1
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa.含具有抗铜绿假单胞菌活性的乳酸菌的吸入性粉末的研制。
Int J Antimicrob Agents. 2024 Jan;63(1):107001. doi: 10.1016/j.ijantimicag.2023.107001. Epub 2023 Oct 13.
2
In vivo assessment and characterization of lactic acid bacteria with probiotic profile isolated from human milk powder.从人乳粉中分离具有益生菌特性的乳酸菌的体内评估和特性分析。
Nutr Hosp. 2021 Feb 23;38(1):152-160. doi: 10.20960/nh.03335.
3
In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.在生物发光铜绿假单胞菌慢性肺部感染模型中,环丙沙星-铜复合物干粉制剂的体内疗效。
Eur J Pharm Biopharm. 2020 Jul;152:210-217. doi: 10.1016/j.ejpb.2020.05.014. Epub 2020 May 20.
4
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.开发可吸入透明质酸/甘露醇复合干粉用于氟胞嘧啶重新定位治疗肺部感染的局部治疗。
J Control Release. 2016 Sep 28;238:80-91. doi: 10.1016/j.jconrel.2016.07.029. Epub 2016 Jul 19.
5
Living, quiescent Lactobacillus plantarum Lp90 probiotic, delivered topically to full thickness tissues in vitro via a just-add-water cream delivery system, stimulates the expression of elastin protein.活的、静止的植物乳杆菌 Lp90 益生菌,通过一种只需加水的乳膏传递系统,局部递送至体外全层组织,可刺激弹性蛋白的表达。
J Cosmet Dermatol. 2023 Oct;22(10):2852-2860. doi: 10.1111/jocd.15927. Epub 2023 Jul 20.
6
Comparative survival of probiotic lactobacilli spray-dried in the presence of prebiotic substances.在益生元物质存在的情况下喷雾干燥的益生菌乳酸杆菌的比较存活率。
J Appl Microbiol. 2004;96(5):1024-39. doi: 10.1111/j.1365-2672.2004.02219.x.
7
New Lactiplantibacillus plantarum and Lacticaseibacillus rhamnosus strains: well tolerated and improve infant microbiota.新型植物乳杆菌和鼠李糖乳杆菌菌株:耐受性良好,可改善婴儿肠道菌群。
Pediatr Res. 2022 Jun;91(7):1849-1857. doi: 10.1038/s41390-021-01678-1. Epub 2021 Aug 24.
8
Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.干粉制剂中噬菌体 PEV20 对铜绿假单胞菌的抗生作用在小鼠肺部感染模型中的原理验证研究。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01714-17. Print 2018 Feb.
9
Development and characterization of a spray-dried inhalable ternary combination for the treatment of Pseudomonas aeruginosa biofilm infection in cystic fibrosis.喷雾干燥可吸入式三联制剂的研制及其用于囊性纤维化铜绿假单胞菌生物膜感染治疗的特性研究。
Eur J Pharm Sci. 2024 Jan 1;192:106654. doi: 10.1016/j.ejps.2023.106654. Epub 2023 Nov 25.
10
Oral administration of Lactobacillus acidophilus alleviates exacerbations in Pseudomonas aeruginosa and Staphylococcus aureus pulmonary infections.口服嗜酸乳杆菌可减轻铜绿假单胞菌和金黄色葡萄球菌肺部感染的病情加重。
Pak J Pharm Sci. 2019 Jul;32(4):1621-1630.

引用本文的文献

1
Activity in an air-liquid interface lung infection model, feasibility of inhaled delivery, and stability of cell-free supernatants from against pulmonary infections.气液界面肺部感染模型中的活性、吸入给药的可行性以及来自……的无细胞上清液对肺部感染的稳定性。 (注:原文中“from”后面似乎缺失了相关内容)
Front Microbiol. 2025 Aug 5;16:1630017. doi: 10.3389/fmicb.2025.1630017. eCollection 2025.
2
Towards airway microbiome engineering for improving respiratory health.致力于气道微生物组工程以改善呼吸健康。
Adv Drug Deliv Rev. 2025 Aug 6;225:115662. doi: 10.1016/j.addr.2025.115662.
3
The Respiratory Tract Microbiome and Human Health.
呼吸道微生物群与人类健康
Microb Biotechnol. 2025 May;18(5):e70147. doi: 10.1111/1751-7915.70147.
4
Alleviates Hyperoxia-Induced BPD by Activating IL-22/STAT3 Signaling Pathway in Neonatal Mice.通过激活新生小鼠的IL-22/STAT3信号通路减轻高氧诱导的支气管肺发育不良
Mediators Inflamm. 2024 Dec 9;2024:4965271. doi: 10.1155/mi/4965271. eCollection 2024.
5
Respiratory Delivery of GG by Vibrating-Mesh and Jet Nebulisation.通过振动网式雾化器和喷射雾化器进行GG的呼吸道给药。
Pharmaceutics. 2024 Oct 14;16(10):1326. doi: 10.3390/pharmaceutics16101326.
6
Dry Powder Inhaler Formulation of Targeting Infection in Bronchiectasis Maintenance Therapy.用于支气管扩张症维持治疗中靶向感染的干粉吸入剂配方
Pharmaceutics. 2024 Jul 25;16(8):980. doi: 10.3390/pharmaceutics16080980.
7
Quality by Design in Pulmonary Drug Delivery: A Review on Dry Powder Inhaler Development, Nanotherapy Approaches, and Regulatory Considerations.质量源于设计在肺部药物传递中的应用:干粉吸入器开发、纳米治疗方法以及监管考虑因素的综述。
AAPS PharmSciTech. 2024 Aug 2;25(6):178. doi: 10.1208/s12249-024-02900-z.
8
Anti-Persisters Activity of Culture Filtrates against in Artificial Sputum Medium.人工痰培养基中培养滤液对 的抗持久菌活性。
Int J Mol Sci. 2024 Jun 28;25(13):7113. doi: 10.3390/ijms25137113.